Gene test may improve TB prevention drug dosing
NCT ID NCT05413551
First seen Jan 05, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study looked at whether using a quick genetic test to adjust the dose of a tuberculosis (TB) prevention drug (isoniazid) could make the treatment more effective. 73 people at risk for TB participated. Researchers measured drug levels in the blood to see if personalized dosing leads to better results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federal University of Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul, Brazil
Conditions
Explore the condition pages connected to this study.